These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36540765)

  • 1. Growth Hormone-Releasing Hormone Antagonist JV-1-36 Suppresses Reactive Oxygen Species Generation in A549 Lung Cancer Cells.
    Kubra KT; Akhter MS; Apperley K; Barabutis N
    Endocrines; 2022 Dec; 3(4):813-820. PubMed ID: 36540765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of reactive oxygen species in endothelial cells by an antagonist of growth hormone-releasing hormone.
    Akhter MS; Barabutis N
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22879. PubMed ID: 34369038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Activities of Growth Hormone-Releasing Hormone Antagonists against Toxin-Induced Endothelial Injury.
    Fakir S; Barabutis N
    Endocrines; 2024 Mar; 5(1):116-123. PubMed ID: 38895505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-releasing hormone antagonists counteract hydrogen peroxide - induced paracellular hyperpermeability in endothelial cells.
    Barabutis N; Siejka A; Akhter MS
    Growth Horm IGF Res; 2023; 69-70():101534. PubMed ID: 37210756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.
    Barabutis N; Schally AV
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20470-5. PubMed ID: 19075233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro.
    Rekasi Z; Varga JL; Schally AV; Halmos G; Groot K; Czompoly T
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1218-23. PubMed ID: 10655511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption.
    Akhter MS; Kubra KT; Barabutis N
    Endocrine; 2023 Mar; 79(3):587-592. PubMed ID: 36261700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers.
    Rekasi Z; Varga JL; Schally AV; Halmos G; Armatis P; Groot K; Czompoly T
    Endocrinology; 2000 Jun; 141(6):2120-8. PubMed ID: 10830299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.
    Rekasi Z; Czompoly T; Schally AV; Boldizsar F; Varga JL; Zarandi M; Berki T; Horvath RA; Nemeth P
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3435-40. PubMed ID: 15728367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities.
    Zarandi M; Varga JL; Schally AV; Horvath JE; Toller GL; Kovacs M; Letsch M; Groot K; Armatis P; Halmos G
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4610-5. PubMed ID: 16537407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.
    Plonowski A; Schally AV; Varga JL; Rekasi Z; Hebert F; Halmos G; Groot K
    Prostate; 2000 Jul; 44(2):172-80. PubMed ID: 10881027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone-releasing hormone antagonists counteract interferon-γ - induced barrier dysfunction in bovine and human endothelial cells.
    Fakir S; Barabutis N
    Cytokine; 2024 Jan; 173():156416. PubMed ID: 37952313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
    Rekasi Z; Schally AV; Plonowski A; Czompoly T; Csernus B; Varga JL
    Prostate; 2001 Aug; 48(3):188-99. PubMed ID: 11494334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation.
    Garcia-Fernandez MO; Schally AV; Varga JL; Groot K; Busto R
    Breast Cancer Res Treat; 2003 Jan; 77(1):15-26. PubMed ID: 12602901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.
    Jaeger LB; Banks WA; Varga JL; Schally AV
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12495-500. PubMed ID: 16118272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone releasing hormone induces the expression of nitric oxide synthase.
    Barabutis N; Siejka A; Schally AV
    J Cell Mol Med; 2011 May; 15(5):1148-55. PubMed ID: 20518847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.
    Letsch M; Schally AV; Busto R; Bajo AM; Varga JL
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1250-5. PubMed ID: 12538852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
    Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
    Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone-releasing hormone antagonists protect against hydrochloric acid-induced endothelial injury in vitro.
    Barabutis N; Kubra KT; Akhter MS
    Environ Toxicol Pharmacol; 2023 Apr; 99():104113. PubMed ID: 36940786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumor growth by growth hormone-releasing hormone antagonist JV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma.
    Kiaris H; Schally AV; Varga JL
    Cancer Lett; 2000 Dec; 161(2):149-55. PubMed ID: 11090963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.